532 related articles for article (PubMed ID: 15059935)
1. Critical role of monocyte chemoattractant protein-1 receptor CCR2 on monocytes in hypertension-induced vascular inflammation and remodeling.
Ishibashi M; Hiasa K; Zhao Q; Inoue S; Ohtani K; Kitamoto S; Tsuchihashi M; Sugaya T; Charo IF; Kura S; Tsuzuki T; Ishibashi T; Takeshita A; Egashira K
Circ Res; 2004 May; 94(9):1203-10. PubMed ID: 15059935
[TBL] [Abstract][Full Text] [Related]
2. Essential role of vascular endothelial growth factor in angiotensin II-induced vascular inflammation and remodeling.
Zhao Q; Ishibashi M; Hiasa K; Tan C; Takeshita A; Egashira K
Hypertension; 2004 Sep; 44(3):264-70. PubMed ID: 15262905
[TBL] [Abstract][Full Text] [Related]
3. Essential role of angiotensin II type 1a receptors in the host vascular wall, but not the bone marrow, in the pathogenesis of angiotensin II-induced atherosclerosis.
Koga J; Egashira K; Matoba T; Kubo M; Ihara Y; Iwai M; Horiuchi M; Sunagawa K
Hypertens Res; 2008 Sep; 31(9):1791-800. PubMed ID: 18971558
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow-derived monocyte chemoattractant protein-1 receptor CCR2 is critical in angiotensin II-induced acceleration of atherosclerosis and aneurysm formation in hypercholesterolemic mice.
Ishibashi M; Egashira K; Zhao Q; Hiasa K; Ohtani K; Ihara Y; Charo IF; Kura S; Tsuzuki T; Takeshita A; Sunagawa K
Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):e174-8. PubMed ID: 15331433
[TBL] [Abstract][Full Text] [Related]
5. Targeting the calpain/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertension.
Letavernier E; Perez J; Bellocq A; Mesnard L; de Castro Keller A; Haymann JP; Baud L
Circ Res; 2008 Mar; 102(6):720-8. PubMed ID: 18258859
[TBL] [Abstract][Full Text] [Related]
6. HMG-CoA reductase inhibition reduces monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated monocyte recruitment in vivo.
Han KH; Ryu J; Hong KH; Ko J; Pak YK; Kim JB; Park SW; Kim JJ
Circulation; 2005 Mar; 111(11):1439-47. PubMed ID: 15781755
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II/salt-induced aortic remodeling.
Weisberg AD; Albornoz F; Griffin JP; Crandall DL; Elokdah H; Fogo AB; Vaughan DE; Brown NJ
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):365-71. PubMed ID: 15576638
[TBL] [Abstract][Full Text] [Related]
8. Losartan reduces monocyte chemoattractant protein-1 expression in aortic tissues of 2K1C hypertensive rats.
Xie QY; Sun M; Yang TL; Sun ZL
Int J Cardiol; 2006 Jun; 110(1):60-6. PubMed ID: 16242797
[TBL] [Abstract][Full Text] [Related]
9. A proteomic analysis of aorta from spontaneously hypertensive rat: RhoGDI alpha upregulation by angiotensin II via AT(1) receptor.
Bian YL; Qi YX; Yan ZQ; Long DK; Shen BR; Jiang ZL
Eur J Cell Biol; 2008 Feb; 87(2):101-10. PubMed ID: 17963997
[TBL] [Abstract][Full Text] [Related]
10. Aortic adventitial fibroblasts participate in angiotensin-induced vascular wall inflammation and remodeling.
Tieu BC; Ju X; Lee C; Sun H; Lejeune W; Recinos A; Brasier AR; Tilton RG
J Vasc Res; 2011; 48(3):261-72. PubMed ID: 21099231
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition.
Okazaki H; Minamino T; Tsukamoto O; Kim J; Okada K; Myoishi M; Wakeno M; Takashima S; Mochizuki N; Kitakaze M
Hypertens Res; 2006 Apr; 29(4):277-84. PubMed ID: 16778335
[TBL] [Abstract][Full Text] [Related]
12. Monocyte chemoattractant protein-1 is an essential inflammatory mediator in angiotensin II-induced progression of established atherosclerosis in hypercholesterolemic mice.
Ni W; Kitamoto S; Ishibashi M; Usui M; Inoue S; Hiasa K; Zhao Q; Nishida K; Takeshita A; Egashira K
Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):534-9. PubMed ID: 14739122
[TBL] [Abstract][Full Text] [Related]
13. Rat aortic MCP-1 and its receptor CCR2 increase with age and alter vascular smooth muscle cell function.
Spinetti G; Wang M; Monticone R; Zhang J; Zhao D; Lakatta EG
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1397-402. PubMed ID: 15178559
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II type 1a receptor is involved in cell infiltration, cytokine production, and neovascularization in infarcted myocardium.
Toko H; Zou Y; Minamino T; Masaya M; Harada M; Nagai T; Sugaya T; Terasaki F; Kitaura Y; Komuro I
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):664-70. PubMed ID: 14962948
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
[TBL] [Abstract][Full Text] [Related]
16. Collateral artery growth (arteriogenesis) after experimental arterial occlusion is impaired in mice lacking CC-chemokine receptor-2.
Heil M; Ziegelhoeffer T; Wagner S; Fernández B; Helisch A; Martin S; Tribulova S; Kuziel WA; Bachmann G; Schaper W
Circ Res; 2004 Mar; 94(5):671-7. PubMed ID: 14963007
[TBL] [Abstract][Full Text] [Related]
17. M2 macrophage accumulation in the aortic wall during angiotensin II infusion in mice is associated with fibrosis, elastin loss, and elevated blood pressure.
Moore JP; Vinh A; Tuck KL; Sakkal S; Krishnan SM; Chan CT; Lieu M; Samuel CS; Diep H; Kemp-Harper BK; Tare M; Ricardo SD; Guzik TJ; Sobey CG; Drummond GR
Am J Physiol Heart Circ Physiol; 2015 Sep; 309(5):H906-17. PubMed ID: 26071547
[TBL] [Abstract][Full Text] [Related]
18. Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets.
Schober A; Zernecke A; Liehn EA; von Hundelshausen P; Knarren S; Kuziel WA; Weber C
Circ Res; 2004 Nov; 95(11):1125-33. PubMed ID: 15528472
[TBL] [Abstract][Full Text] [Related]
19. Role of angiotensin-converting enzyme 2 in cardiac hypertrophy induced by nitric oxide synthase inhibition.
Inaba S; Iwai M; Furuno M; Kanno H; Senba I; Okayama H; Mogi M; Higaki J; Horiuchi M
J Hypertens; 2011 Nov; 29(11):2236-45. PubMed ID: 21946695
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II type 1 receptor antagonist and angiotensin-converting enzyme inhibitor altered the activation of Cu/Zn-containing superoxide dismutase in the heart of stroke-prone spontaneously hypertensive rats.
Tanaka M; Umemoto S; Kawahara S; Kubo M; Itoh S; Umeji K; Matsuzaki M
Hypertens Res; 2005 Jan; 28(1):67-77. PubMed ID: 15969257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]